Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1538188

	registered interest
	date	01/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ageing: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the UK maximises the potential merits of the role AI and future technology in helping people to live well in later life.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	76012
	answer	answer is ministerial correction date of answer 11/11/2022 answer text <p>Through its Artificial Intelligence in Health and Care Award, the NHS Artificial Intelligence Laboratory is funding research into testing of leading AI imaging and diagnostic technologies, which could provide faster cancer and stroke diagnoses. Other technologies funded through the Award can assist with managing health conditions such as heart disease and chronic obstructive pulmonary disease at home and reduce regular hospital visits.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/11/2022 14:59:27 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1538191

	registered interest
	date	01/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ageing: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding his Department has provided to research and development on understanding the potential merits of using AI technology to support people as they age.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	76014
	answer	answer is ministerial correction date of answer 11/11/2022 answer text <p>The NHS Artificial Intelligence Laboratory has invested more than £100 million to support testing and evaluation of 77 technologies through its Artificial Intelligence in Health and Care Award. The Award was established in 2020 and the funding is available for four years.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/11/2022 14:57:49 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1538192

	registered interest
	date	01/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ageing: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will set up a National Institute for AI and Ageing as recommended in a recent report by the Institution of Engineering and Technology.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	76015
	answer	answer is ministerial correction date of answer 11/11/2022 answer text <p>The NHS Artificial Intelligence Laboratory is addressing aging in a multi-disciplinary, cross-sector approach. The Laboratory is contributing to a range of projects, including identifying whether artificial intelligence (AI) can be used to detect the earlier onset of Parkinson's disease to enable a proactive approach to care; funding a range of ethics focused research projects to identify how all demographic groups can benefit from AI; and deploying imaging technologies which can detect the prevalence of conditions such as osteoporosis.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/11/2022 14:55:45 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1657370

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merit of each Intrgetated Care System having a (a) specialist allergy nurse and (b) specialist dietician.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	196976
	answer	answer is ministerial correction date of answer 08/09/2023 answer text <p>No assessment has been made. Most services for people living with allergies are commissioned locally through integrated care boards, which are best placed to commission services according to local need.</p> answering member constituency Colchester answering member printed Will Quince question first answered 08/09/2023 13:12:19 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1657371

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to mitigate increases in the number of hospital admissions associated with (a) allergies and (b) anaphylaxis.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	196977
	answer	answer is ministerial correction date of answer 11/09/2023 answer text <p>People with allergies continue to be supported through locally commissioned NHS services. For people with rare and complex allergic conditions, specialised allergy services are commissioned by NHS England in line with the published service specification.</p><p>The National Institute of Health and Care Excellence (NICE) has produced a range of guidance to support the care of people with allergies, including recommendations on what information and support should be provided to the child or young person and their families to help manage one’s condition and avoid unnecessary hospital admissions.</p><p>On 1 October 2021, Natasha’s Law made it a legal requirement for food operators to display allergen labelling on food items pre-packed for direct sale, protecting those with allergies and giving them more confidence in the food they buy.</p><p>The Food Standards Agency (FSA) is currently considering how to improve the provision of information for people with allergies and are researching different approaches for the provision of written and verbal information to improve the accuracy and communications of allergen information. The FSA has recently commissioned several pieces of research in this area. These will provide new evidence on the nature and extent of food hypersensitivity reactions, different international approaches to written information, and the business operating models of small and micro businesses in the non-prepacked sector. These reports will be published in due course and will be presented to the FSA Board to consider next steps.</p><p>In June 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) published new guidance on the use adrenaline auto-injectors (AAIs), highlighting the latest safety advice on the steps to take during anaphylaxis. The new guidance includes a step infographic guide and video outlining the latest advice from the Commission on Human Medicines (CHM’s) working group on the safe and effective use of AAIs. It includes an easy step-by-step guide on what to do in an emergency and provides updated advice on body positioning.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/09/2023 11:20:36 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1657372

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to adopt Allergy UK's Patient Charter as a plan for patient rights for people living with allergic conditions.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	196978
	answer	answer is ministerial correction date of answer 11/09/2023 answer text <p>The majority of allergy services are commissioned locally by integrated care boards, with a small number of specialist allergy services for patients with complex and severe allergies commissioned nationally by NHS England. The service specification specifies that centres provide equity of access to best practice standards for diagnosis and management, based on current national and international guidelines.</p><p>The Department and NHS England continue to engage with stakeholders, including Allergy UK, to understand the needs of people with allergies and how services could be improved. This includes patient and public voice membership in NHS England’s clinical reference group which provides clinical advice and leadership on specialised immunology and allergy services.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/09/2023 13:24:27 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1506394

	registered interest
	date	08/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce levels of bowel cancer in the UK.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	49738
	answer	answer is ministerial correction date of answer 22/09/2022 answer text <p>Since 2019, the National Health Service Bowel Cancer Screening Programme (BCSP) in England has issued a faecal immunochemical test (FIT) kit to eligible people for use at home, which can detect changes in the bowel which, if left untreated, could lead to cancer. The FIT kit requires one sample to be taken and replaced the previous test which required three samples, which has increased uptake in England.</p><p>The FIT home testing kit is currently available to everyone aged 60 to 74 years old and the majority of 56-year-olds. The NHS BCSP is expanding the FIT kit offer to 58-year-olds and the programme will be offered to all those aged 50 to 74 years old by 2025. In 2023, an NHS bowel cancer screening communications and marketing campaign is planned to increase the uptake of the FIT home testing kit in eligible people across England.</p><p>Obesity can increase the likelihood of developing bowel cancer therefore we have introduced measures to help people to achieve and maintain a healthier weight. New Regulations on out-of-home calorie labelling for out of home food sold in large businesses including restaurants, cafes and takeaways came into force on 6 April 2022. These aim to ensure people can make more informed, healthier choices when eating food out or ordering takeaways. We are also working to make the food and drink that is available to consumers healthier through reformulation programmes.</p><p>Reducing tobacco use and supporting smokers to quit can prevent 15 types of cancers, including bowel cancer. An independent review of the Government’s tobacco control policies led by Javed Khan, published on 9 June 2022, makes recommendations to support the Government’s ambition for England to be smoke-free by 2030. We are currently considering the recommendations to inform a new Tobacco Control Plan.</p> answering member constituency Colchester answering member printed Will Quince question first answered 22/09/2022 10:40:57 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1503657

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an impact assessment of the regulations prohibiting regulated manufacture of medical cannabis and CBD products on patient safety.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	45233
	answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>The manufacture of cannabis-based medicines is allowed under the appropriate Medicines and Healthcare products Regulatory Agency and Home Office licences. Cannabis-based medicines must comply with all applicable requirements and high standards of manufacture that apply to all other medicines to ensure patient safety.</p><p>In 2018, the Government amended the law to allow specialist doctors to prescribe unlicensed cannabis-based products for medicinal use, where clinically appropriate, with an accompanying impact assessment published by the Home Office. The Government must consider advice from the Advisory Council on the Misuse of Drugs (ACMD) before making any further amendments to the law in this area. At the request of the Home Office, the ACMD have recently reviewed this legislation and concluded that no amendments are currently required.</p><p>Cannabidiol (CBD) in its pure form is not a controlled drug. However, many consumer CBD products also contain varying amounts of controlled cannabinoids due to difficulties in isolating pure CBD. The Home Office has sought the ACMD’s advice on a legal framework exempting CBD products with a defined trace percentage of controlled cannabinoids from control under the Misuse of Drugs Act 1971. The ACMD responded on December 17 2021 and the Government is currently considering this advice.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 45491 question first answered 21/09/2022 13:46:46 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1503788

	registered interest
	date	02/09/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will take steps to reform regulations relating to the production of cannabis-based medicinal products to support UK patients and businesses.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	45491
	answer	answer is ministerial correction date of answer 21/09/2022 answer text <p>The manufacture of cannabis-based medicines is allowed under the appropriate Medicines and Healthcare products Regulatory Agency and Home Office licences. Cannabis-based medicines must comply with all applicable requirements and high standards of manufacture that apply to all other medicines to ensure patient safety.</p><p>In 2018, the Government amended the law to allow specialist doctors to prescribe unlicensed cannabis-based products for medicinal use, where clinically appropriate, with an accompanying impact assessment published by the Home Office. The Government must consider advice from the Advisory Council on the Misuse of Drugs (ACMD) before making any further amendments to the law in this area. At the request of the Home Office, the ACMD have recently reviewed this legislation and concluded that no amendments are currently required.</p><p>Cannabidiol (CBD) in its pure form is not a controlled drug. However, many consumer CBD products also contain varying amounts of controlled cannabinoids due to difficulties in isolating pure CBD. The Home Office has sought the ACMD’s advice on a legal framework exempting CBD products with a defined trace percentage of controlled cannabinoids from control under the Misuse of Drugs Act 1971. The ACMD responded on December 17 2021 and the Government is currently considering this advice.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 45233 question first answered 21/09/2022 13:46:46 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day

1548834

	registered interest
	date	06/12/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the cost implications for patients suffering from chronic pain of accessing private medicinal cannabis prescriptions.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	104217
	answer	answer is ministerial correction date of answer 14/12/2022 answer text <p>The Government revised the law to allow specialist doctors to prescribe cannabis-based products, where clinically appropriate and in the best interests of patients. However, the National Institute for Health and Care Excellence does not recommend that cannabis-based medicines are offered to manage chronic pain due to lack of evidence on safety and efficacy and recommends further research. Until such evidence is available, no assessment can be made on cost effectiveness. The funding of private prescriptions is the responsibility of patients seeking those treatments.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 104218 question first answered 14/12/2022 12:02:16 answering member 4423 label Biography information for Will Quince
	tabling member	4488 label Biography information for Martyn Day